FKBP11 and type 2 diabetes mellitus: FKBP11 is involved in the regulation of mTOR (Hausch et al., 2013; Wang et al., 2019) and the pathogenesis of stress-related inflammatory diseases, including type 2 diabetes mellitus, systemic lupus erythematosus, and hepatitis (Ruer-Laventie et al., 2015; Wang et al., 2017, 2018).